Jubilant Ingrevia quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	1,394	1,121	+24.4%
EBITDA	212	136	+56.7%
EBITDA margin	15.2%	12.1%	+3.1 pts
Profit before tax	148	92.9	+59.3%
Net profit	111	69.5	+60.4%
EPS	₹7.07	₹4.40	+60.7%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	1,394	1,300	1,179	1,051	1,121	1,038	1,051	1,057	1,045	1,024	1,074	966	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	9.0	10.2	9.3	9.4	10.8	11.2	8.4	9.4	10.5	9.6	9.5	8.8
	1,403	1,310	1,188	1,060	1,132	1,049	1,060	1,066	1,056	1,034	1,084	975
	698	718	597	510	548	449	481	525	512	532	488	501
	22.9	64.1	44.4	41.7	30.6	32.4	32.2	9.0	8.2	7.4	13.4	18.1
	0.8	−153	−23.0	4.0	22.0	38.1	19.6	4.2	−12.8	−10.8	94.9	−10.7
	122	117	106	104	108	108	96.0	105	113	102	85.9	101
	22.5	17.4	11.8	12.5	12.2	12.7	13.9	12.4	15.1	14.3	13.6	15.1
	50.9	51.0	48.4	45.0	41.2	40.8	39.4	39.8	39.6	38.9	35.7	34.2
	338	355	291	265	277	268	276	275	301	285	301	261
	1,255	1,170	1,076	982	1,039	949	958	971	975	968	1,033	920
	212	199	163	127	136	142	147	138	125	110	91.2	95.6
	161	148	114	81.5	94.3	101	107	98.5	85.0	70.7	55.5	61.3
Profit
	148	141	112	78.5	92.9	99.8	102	95.6	80.4	66.0	51.4	55.1
	0.0	0.0	0.0	−13.0	0.0	0.0	0.0	0.0	−0.1	0.0	0.0	0.0
	148	141	112	65.4	92.9	99.8	102	95.6	80.2	66.0	51.4	55.1
	23.1	43.0	27.5	18.2	15.3	23.2	25.3	22.0	25.5	12.5	22.3	11.9
	13.4	−7.9	−2.2	0.3	8.1	1.5	2.5	4.2	−4.3	4.8	−0.2	4.6
	36.6	35.0	25.3	18.5	23.4	24.7	27.7	26.2	21.2	17.3	22.1	16.5
	−0.0	−0.0	−0.0	−0.0	−0.1	−0.1	0.0	0.0	0.0	0.1	−0.1	0.0
	111	106	86.4	46.9	69.5	75.1	74.1	69.4	59.0	48.7	29.3	38.6
	111	106	86.5	46.9	69.6	75.2	74.0	69.4	59.0	48.7	29.3	38.5
	−1.7	5.1	2.1	0.7	7.5	10.1	6.0	−7.4	1.5	1.6	3.3	0.8
	110	111	88.6	47.6	76.9	85.2	80.1	62.0	60.5	50.4	32.6	39.3
	111	106	86.4	46.9	69.5	75.1	74.1	69.4	59.0	48.7	29.3	38.6
Per share
	₹7.07	₹6.70	₹5.47	₹2.97	₹4.40	₹4.75	₹4.69	₹4.39	₹3.73	₹3.08	₹1.85	₹2.44
	₹7.06	₹6.68	₹5.39	₹2.97	₹4.40	₹4.75	₹4.64	₹4.39	₹3.73	₹3.08	₹1.85	₹2.43
Other comprehensive income — detail
	−1.7	5.1	2.1	0.7	7.5	10.1	6.0	—	—	—	—	—
	−4.5	2.7	−3.9	−1.2	4.4	1.6	0.9	−1.8	−3.0	2.0	5.4	−1.3
	−1.2	0.4	−0.5	0.1	0.4	0.2	0.3	—	—	—	—	—
	—	—	—	—	—	—	—	−0.2	−0.7	0.0	1.2	−0.4
	0.8	1.8	7.4	2.6	4.4	11.8	5.1	−6.0	5.6	−0.6	−1.9	3.3
	−0.8	−1.0	1.9	0.7	0.9	3.2	−0.3	—	—	—	—	—
	—	—	—	—	—	—	—	−0.2	1.8	−0.3	−1.0	1.6
	110	111	88.6	47.6	76.9	85.2	80.1	62.0	60.5	50.4	32.6	39.3
Per share — as-filed variants
	₹7.07	₹6.70	₹5.47	₹2.97	₹4.40	₹4.75	₹4.69	₹4.39	₹3.73	₹3.08	₹1.85	₹2.44
	₹7.06	₹6.68	₹5.39	₹2.97	₹4.40	₹4.75	₹4.64	₹4.39	₹3.73	₹3.08	₹1.85	₹2.43
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	673	672	560	495	520	519	518	518	538	496	479	458
	48.2%	51.7%	47.5%	47.1%	46.4%	50.0%	49.3%	49.0%	51.5%	48.4%	44.5%	47.4%
Adjusted (ex-exceptional items) — derived
	148	141	112	78.5	92.9	99.8	102	95.6	80.4	66.0	51.4	55.1
	0.0	0.0	0.0	−13.0	0.0	0.0	0.0	0.0	−0.1	0.0	0.0	0.0
	111	106	86.4	56.3	69.5	75.1	74.1	69.4	59.1	48.7	29.3	38.6
	₹7.07	₹6.70	₹5.47	₹3.56	₹4.40	₹4.75	₹4.69	₹4.39	₹3.74	₹3.08	₹1.85	₹2.44

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JUBLINGREA₹604.00

Jubilant Ingrevia Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersVIDHIING PARADEEP PCBL FACT OAL IGPL PAUSHAKLTD TIRUMALCHMMcap ₹9,543 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	966.4	1,074.4	1,024.3	1,045.2	1,056.8	1,051.3	1,038.0	1,120.7	1,051.0	1,178.7	1,300.3	1,394.2
Other Income	8.8	9.5	9.6	10.5	9.4	8.4	11.2	10.8	9.4	9.3	10.2	9.0
Total Income	975.2	1,083.9	1,033.9	1,055.7	1,066.2	1,059.6	1,049.2	1,131.5	1,060.4	1,188.0	1,310.5	1,403.3
Expenses
+ Cost of Materials Consumed	501.1	487.6	532.0	511.8	525.4	481.1	448.9	548.0	510.4	597.4	717.7	697.9
+ Purchases of Stock-in-Trade	18.1	13.4	7.4	8.2	9.0	32.2	32.4	30.6	41.7	44.4	64.1	22.9
+ Changes in Inventories	-10.7	94.9	-10.8	-12.8	4.2	19.6	38.1	22.0	4.0	-23.0	-153.2	0.8
+ Employee Benefit Expense	101.1	85.9	101.5	112.7	105.2	96.0	108.2	107.5	103.6	106.3	117.4	122.1
+ Finance Costs	15.1	13.6	14.3	15.1	12.4	13.9	12.7	12.2	12.5	11.8	17.4	22.5
+ Depreciation & Amortisation	34.2	35.7	38.9	39.6	39.8	39.4	40.8	41.2	45.0	48.4	51.0	50.9
+ Other Expenses	261.1	301.3	284.7	300.9	274.7	275.6	268.1	277.2	264.8	291.0	355.2	338.1
Total Expenses	920.1	1,032.5	968.0	975.3	970.6	957.9	949.3	1,038.6	981.9	1,076.2	1,169.6	1,255.3
EBITDA	95.6	91.2	109.5	124.6	138.3	146.7	142.1	135.5	126.6	162.6	199.1	212.4
EBIT	61.3	55.5	70.7	85.0	98.5	107.3	101.3	94.3	81.5	114.2	148.1	161.5
Profit
PBT before Exceptional Items	55.1	51.4	66.0	80.4	95.6	101.8	99.8	92.9	78.5	111.7	140.9	148.0
+ Exceptional Items	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0	-13.0	0.0	0.0	0.0
Pretax Income	55.1	51.4	66.0	80.2	95.6	101.8	99.8	92.9	65.4	111.7	140.9	148.0
+ Current Tax	11.9	22.3	12.5	25.5	22.0	25.3	23.2	15.3	18.2	27.5	43.0	23.1
+ Deferred Tax	4.6	-0.2	4.8	-4.3	4.2	2.5	1.5	8.1	0.3	-2.2	-7.9	13.4
Tax Expense	16.5	22.1	17.3	21.2	26.2	27.7	24.7	23.4	18.5	25.3	35.0	36.6
+ Share of Associates & JVs	0.0	-0.1	0.1	0.0	0.0	0.0	-0.1	-0.1	-0.0	-0.0	-0.0	-0.0
Net Income	38.6	29.3	48.7	59.0	69.4	74.1	75.1	69.5	46.9	86.4	105.8	111.4
+ Net Income — Continuing Ops	38.5	29.3	48.7	59.0	69.4	74.0	75.2	69.6	46.9	86.5	105.9	111.5
+ Other Comprehensive Income	0.8	3.3	1.6	1.5	-7.4	6.0	10.1	7.5	0.7	2.1	5.1	-1.7
Total Comprehensive Income	39.3	32.6	50.4	60.5	62.0	80.1	85.2	76.9	47.6	88.6	110.9	109.7
Net Income to Common	38.6	29.3	48.7	59.0	69.4	74.1	75.1	69.5	46.9	86.4	105.8	111.4
Per Share
Basic EPS	2.44	1.85	3.08	3.73	4.39	4.69	4.75	4.40	2.97	5.47	6.70	7.07
Diluted EPS	2.43	1.85	3.08	3.73	4.39	4.64	4.75	4.40	2.97	5.39	6.68	7.06
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	6.0	10.1	7.5	0.7	2.1	5.1	-1.7
+ Items NOT to be Reclassified to P&L	-1.3	5.4	2.0	-3.0	-1.8	0.9	1.6	4.4	-1.2	-3.9	2.7	-4.5
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.3	0.2	0.4	0.1	-0.5	0.4	-1.2
+ Tax on Items NOT to be Reclassified — alt tag	-0.4	1.2	0.0	-0.7	-0.2	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	3.3	-1.9	-0.6	5.6	-6.0	5.1	11.8	4.4	2.6	7.4	1.8	0.8
+ Tax on Items to be Reclassified	—	—	—	—	—	-0.3	3.2	0.9	0.7	1.9	-1.0	-0.8
+ Tax on Items to be Reclassified — alt tag	1.6	-1.0	-0.3	1.8	-0.2	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	39.3	32.6	50.4	60.5	62.0	80.1	85.2	76.9	47.6	88.6	110.9	109.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.44	1.85	3.08	3.73	4.39	4.69	4.75	4.40	2.97	5.47	6.70	7.07
Diluted EPS — Continuing Operations	2.43	1.85	3.08	3.73	4.39	4.64	4.75	4.40	2.97	5.39	6.68	7.06
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	457.8	478.5	495.8	538.1	518.1	518.3	518.5	520.2	494.9	559.9	671.7	672.6
Gross Margin %	47.37	44.54	48.40	51.48	49.03	49.30	49.96	46.42	47.09	47.50	51.66	48.24
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	55.1	51.4	66.0	80.4	95.6	101.8	99.8	92.9	78.5	111.7	140.9	148.0
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-0.1	0.0	0.0	0.0	0.0	-13.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	38.6	29.3	48.7	59.1	69.4	74.1	75.1	69.5	56.3	86.4	105.8	111.4
EPS Adj	2.44	1.85	3.08	3.74	4.39	4.69	4.75	4.40	3.56	5.47	6.70	7.07
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	—	1.00	—	—	—	—	—
Filed Debt Equity	—	0.00	0.00	0.00	0.00	0.22	0.23	0.25	—	0.19	0.22	0.21
Filed Dscr	—	7.00	8.00	9.00	6.00	5.94	4.72	4.58	—	4.68	4.81	4.56
Filed Iscr	—	7.00	8.00	9.00	12.00	11.16	12.08	12.02	—	14.55	12.01	9.84
Paid Up Equity Capital	15.8	15.8	15.8	15.8	15.8	15.8	15.8	15.8	15.8	15.8	15.8	15.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Jubilant Ingrevia Q2 FY27 results (July–September 2026)

Jubilant Ingrevia (NSE: JUBLINGREA) reported its Q2 FY27 results (July–September 2026). Consolidated net profit was ₹111 crore, up 60.4% from ₹69.5 crore in Q2 FY26 and up 5.3% from ₹106 crore in Q1 FY27. Revenue from operations was ₹1,394 crore, up 24.4% year on year and up 7.2% from the previous quarter.

Q2 FY26 results (a year earlier): 27 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹111 Cr+60.4% vs Q2 FY26+5.3% vs Q1 FY27
Revenue from operations: ₹1,394 Cr+24.4% vs Q2 FY26+7.2% vs Q1 FY27
Operating margin (EBIT): 11.6%+3.2 pts vs Q2 FY26+0.2 pts vs Q1 FY27EBIT ₹161 Cr
EBITDA: ₹212 Cr+56.7% vs Q2 FY26+6.7% vs Q1 FY27margin 15.2%
Earnings per share (basic): ₹7.07+60.7% vs Q2 FY26+5.5% vs Q1 FY27
Net profit margin: 8.0%+1.8 pts vs Q2 FY26−0.1 pts vs Q1 FY27

Questions

What was Jubilant Ingrevia's net profit in Q2 FY27?

Consolidated net profit was ₹111 crore, up 60.4% from ₹69.5 crore in Q2 FY26 and up 5.3% from ₹106 crore in Q1 FY27.

What was Jubilant Ingrevia's revenue in Q2 FY27?

Revenue from operations was ₹1,394 crore, up 24.4% year on year and up 7.2% from the previous quarter.

What is Jubilant Ingrevia's net profit margin?

Jubilant Ingrevia's net profit margin was 8.0% in Q2 FY27 (net profit as a share of revenue from operations), against 6.2% in Q2 FY26 (up 1.8 percentage points). For FY26 as a whole it was 6.3%.

How were Jubilant Ingrevia's Q2 FY27 results?

Both grew from a year earlier: net profit was up 60.4% at ₹111 crore and revenue was up 24.4% at ₹1,394 crore. The operating margin was 11.6%, up 3.2 percentage points from 8.4% a year earlier. Against Q1 FY27, net profit was up 5.3% and revenue up 7.2%.

What was Jubilant Ingrevia's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹161 crore, a margin of 11.6%, against 11.4% in Q1 FY27 and 8.4% in Q2 FY26. EBITDA was ₹212 crore, 15.2% of revenue.

What was Jubilant Ingrevia's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹217 crore, up 50.3% from ₹145 crore in the same months a year earlier. Revenue from operations was ₹2,695 crore, up 24.8%.

What was Jubilant Ingrevia's EPS in Q2 FY27?

Basic earnings per share were ₹7.07, against ₹4.40 in Q2 FY26.

What was Jubilant Ingrevia's net profit in FY26?

Consolidated net profit was ₹278 crore in FY26 (April 2025–March 2026), up 10.6% from ₹251 crore in FY25. It was ₹183 crore in FY24 and ₹308 crore in FY23: down 9.6% over three years, an average fall of 3.3% a year.

What was Jubilant Ingrevia's revenue in FY26?

Revenue from operations was ₹4,388 crore in FY26 (April 2025–March 2026), up 5.0% from ₹4,178 crore in FY25. It was ₹4,136 crore in FY24 and ₹4,773 crore in FY23: down 8.1% over three years, an average fall of 2.8% a year.

How has Jubilant Ingrevia's profit changed over the last four quarters?

Net profit by quarter: ₹46.9 crore in Q3 FY26, ₹86.4 crore in Q4 FY26, ₹106 crore in Q1 FY27 and ₹111 crore in Q2 FY27. That is ₹351 crore over the four quarters, up 21.7% from ₹288 crore in the four quarters before. Revenue from operations: ₹1,051 crore, ₹1,179 crore, ₹1,300 crore and ₹1,394 crore.

When will Jubilant Ingrevia announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Jubilant Ingrevia figures come from?

From Jubilant Ingrevia's own consolidated results filings to NSE, in ₹ crore as filed. Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.